Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCRX5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,990
Award facts
- Contract value 100% obligated
- $37,989.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $37,989.81 to DMS Pharmaceutical Group Inc. on February 4, 2026, for the supply of Jakafi 10 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The firm fixed-price delivery order is scheduled for completion by February 5, 2026, with performance to be executed at the contractor's Park Ridge, Illinois facility.
This delivery order operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded November 13, 2025, with a $499.9 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents part of the broader $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical products—including oncology treatments, biologics, vaccines, and specialty pharmaceuticals—positions the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCRX5?
SPE2DR26FCRX5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FCRX5 worth?
The government has obligated $37,990 on SPE2DR26FCRX5.
Is contract SPE2DR26FCRX5 an order under another contract?
Yes. SPE2DR26FCRX5 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRX5 competed?
The extent of competition for SPE2DR26FCRX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award